This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Valsartan-HCTZ 320-25 mg tablets. The $6,361.52 firm fixed-price delivery order contract has an ultimate completion date of October 21, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a comprehensive vehicle for providing a range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award demonstrates AmerisourceBergen's role as a key vendor for essential medical commodities to federal agencies, particularly the DLA which oversees procurement for the military healthcare system.
Generated 1/17/25, 9:19 AM